CASI Pharmaceuticals's market cap is currently $31.45M. The company's EPS TTM is $-0.86; its P/E ratio is ―; CASI Pharmaceuticals is scheduled to report earnings on August 29, 2025, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.
